Resources

The Minister for Health and Aged Care must declare a facility to be a hospital under section 121–5(6) of the Private Health Insurance Act 2007. View the current list of declared hospitals.

The document contains advice on the third and final reduction of benefits for Cardiac Implantable Electronic Devices (CIED) effective 1 July 2025.

The Hospital Casemix Protocol (HCP) data specifications for HCP files details the financial, clinical and demographic data that hospitals must provide to private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2025.

The Hospital Casemix Protocol (HCP) data specification for HCP1 files for 2025–26 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2025.

The Hospital Casemix Protocol (HCP) data specification for HCP2 files for 2025–26 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2025.

The Hospital Casemix Protocol (HCP) data specification for General Treatment-Dental files for 2025–26 details the financial, clinical and demographic data that hospitals must provide private health insurers. Private health insurers must then provide this data to us. Effective from 1 July 2025.

The Private Health Data Bureau (PHDB) data specifications for 2024–25 details the financial, clinical and demographic data that hospitals must provide to us. Effective from 1 July 2025.

This fact sheet outlines changes in the data specifications for Hospital Casemix Protocol (HCP) and Private Hospital Data Bureau (PHDB) data for the 2025–26 financial year. They take effect on 1 July 2025.

Read the final report from the Chair of the Natural Therapies Review Expert Advisory Panel. The review considered a range of natural therapies and recommends which ones should be eligible for subsidy through private health insurance rebates.

Natural Therapies Review Expert Advisory Panel (NTREAP) meeting outcomes for 10 December 2024 meeting.

Standard clinical category definitions for private health insurance hospital policies, released on 19 February 2025 and effective 1 March 2025.

This page lists the medical devices and human tissue products private health insurers must pay benefits for to the patients who have appropriate insurance policies. The latest version of the Prescribed List is effective from 1 March 2025.

This preliminary annual report of Private Hospital Data Bureau (PHDB) data outlines health statistics received from private hospitals detailing information relating to patient data for the financial years 2019-20 to 2023-24.

This preliminary annual report of Hospital Casemix Protocol (HCP) data outlines health statistics received from private health insurers detailing information relating to patient, medical and financial data for the financial years 2019-20 to 2023-24.

This document provides a high-level summary of stakeholder feedback received in response to Consultation Paper 9 – CIED and the cost of technical support services.

This report from the National Health and Medical Research Council (NHMRC) details the methods used to assess, for a range of therapies, whether they are suitable to be covered by private health insurance.

We have developed a Prescribed List Post-listing Review Framework that is used to guide the post-listing review process as part of the Prescribed List Reforms.

Standard clinical category definitions for private health insurance hospital policies, released on 12 December 2024 and effective 1 January 2025.

This spreadsheet classifies MBS items by private health insurance clinical category or procedure type and includes MBS items effective 1 January 2025.

The interim evaluation report covers the period from May 2021 to June 2024 and reports on whether the reforms being implemented and achieving the expected outcomes.

This report is to provide an analysis of stakeholder feedback received.

A summary of 2023 funds returned from private health insurers to policyholders in response to the COVID-19 pandemic.

A summary of 2024 funds returned from private health insurers to policyholders in response to the COVID-19 pandemic.